Biogen shares jump 4.7% premarket on hopes for its Alzheimer’s treatment lecanemab
Biogen Inc. shares BIIB, +5.07% rose 4.7% in premarket trade Monday, after MorphoSys and partner Roche said a trial of a treatment for Alzheimer’s disease failed to meet…
Read more Biogen shares jump 4.7% premarket on hopes for its Alzheimer’s treatment lecanemab